Biological Age Calculator: What Your Blood Work Actually Reveals

Your date of birth is a poor predictor of how long you'll live. Two 50-year-olds with the same chronological age can have bodies that are biologically a decade apart. In 2018, Morgan Levine and colleagues at Yale published a formula in the journal Aging that calculates biological age from nine routine blood biomarkers — values available from a standard CBC and metabolic panel that most men over 40 already have on file.

The formula, called PhenoAge, predicted 10-year all-cause mortality better than chronological age alone. Each year of biological-chronological age difference corresponded to a 9% change in mortality risk. The calculator below runs the same math on your numbers.

What PhenoAge Measures

PhenoAge is a composite score derived from a parametric survival model trained on NHANES data — a nationally representative sample of US adults with long-term mortality follow-up. The nine biomarkers were selected because they collectively predicted survival across multiple disease categories: cardiovascular, metabolic, immune, and organ function.

The formula combines them into a single mortality probability, then converts that probability back into a biological age in years. A result of 42 for a 50-year-old means: this person's biomarker profile matches the 10-year mortality risk of an average 42-year-old.

What makes it useful is that all nine inputs are modifiable. Unlike genetic age clocks (which measure epigenetic methylation patterns and require specialized lab analysis costing $200–$500), PhenoAge uses biomarkers that respond to diet, exercise, sleep, and medical treatment.

The Nine Biomarkers — What Each One Signals

Albumin (g/dL) — The strongest single predictor in the formula. Albumin is a protein synthesized by the liver that carries hormones, drugs, and nutrients through the bloodstream. Low albumin reflects poor nutrition, liver dysfunction, chronic inflammation, or kidney disease. Normal range: 3.5–5.0 g/dL. Optimal for longevity: above 4.0 g/dL.

Creatinine (mg/dL) — A byproduct of muscle metabolism, filtered by the kidneys. Rising creatinine signals declining kidney function. Normal range for men: 0.7–1.2 mg/dL. Both extremes matter: very low creatinine suggests low muscle mass; high creatinine suggests kidney stress.

Glucose (mg/dL, fasting) — The most actionable biomarker in the panel. Fasting glucose above 100 mg/dL indicates insulin resistance; above 126 mg/dL meets the diagnostic threshold for diabetes. Chronically elevated glucose drives glycation, inflammation, and organ damage across multiple systems. Target: below 90 mg/dL fasting.

C-reactive protein (mg/L) — A direct marker of systemic inflammation produced by the liver in response to inflammatory signaling. CRP below 1 mg/L is optimal; 1–3 mg/L is elevated; above 3 mg/L is high. Because the formula uses the natural log of CRP, improvements at the lower end (e.g., dropping from 3 to 1 mg/L) have a proportionally larger effect on PhenoAge than improvements at the higher end.

Lymphocyte percentage (%) — The fraction of white blood cells that are lymphocytes, the adaptive immune system's primary cell type. Declining lymphocyte percentage with age reflects immunosenescence — the gradual erosion of immune function. Normal range: 20–40%.

Mean cell volume (fL) — The average size of red blood cells. Elevated MCV suggests B12 or folate deficiency; reduced MCV suggests iron deficiency. Both extremes impair oxygen delivery and reflect nutritional gaps common in men over 40 who eat restrictively. Normal range: 80–100 fL.

Red cell distribution width (%) — The variation in red blood cell size. High RDW signals that the bone marrow is producing cells of inconsistent quality — a marker of nutritional deficiency, chronic disease, or oxidative stress. RDW carries the highest coefficient in the PhenoAge formula (0.3306), making it the single biggest driver of the score after age itself. Normal range: 11.5–14.5%.

Alkaline phosphatase, ALP (U/L) — An enzyme present in bone, liver, and kidneys. Elevated ALP suggests bone turnover, liver stress, or bile duct issues. Normal range for adult men: 44–147 U/L.

White blood cell count (K/µL) — Total immune cell count. Chronically elevated WBC reflects immune activation, often driven by infection, inflammation, obesity, or smoking. Low WBC can indicate immunosuppression. Normal range: 4.5–11.0 K/µL. Optimal for longevity: 4.5–7.0 K/µL.

Why This Beats a Single Biomarker

Each biomarker above reflects a different biological system. Glucose alone captures metabolic health; albumin captures liver and nutritional status; CRP captures inflammatory load; RDW captures hematopoietic stress. No single value tells the full story.

The power of PhenoAge is that it weights these signals by their mortality relevance and integrates them into one number. A man with excellent glucose but very high RDW and elevated CRP will score older than his peers. A man with borderline glucose but strong albumin, low CRP, and normal RDW may score younger despite imperfect metabolic control.

The delta — your PhenoAge minus your chronological age — is the number that matters. In the original study, men with a negative delta (biologically younger than chronological age) had substantially lower 10-year mortality across all age groups.

How to Get These Values

All nine biomarkers come from two tests that a primary care doctor can order at any annual physical:

CBC with differential — Complete blood count. Provides: WBC, lymphocyte %, MCV, RDW.

Comprehensive metabolic panel (CMP) — Provides: albumin, creatinine, glucose, alkaline phosphatase.

Add-on: hs-CRP — High-sensitivity C-reactive protein. Not included in standard panels but easily added; most labs run it for under $15.

If you have recent labs (within 12 months), you likely already have eight of the nine values. The only one that requires a specific order is hs-CRP.

Direct-to-consumer options — In most US states, you can order these without a doctor's prescription through LabCorp Patient, Quest MyQuest, Ulta Lab Tests, or Let's Get Checked. A full panel including hs-CRP typically runs $40–$80.

What Moves the Score

The biomarkers in PhenoAge respond to intervention. Research on each component:

Glucose responds to: dietary carbohydrate reduction, zone 2 cardio (improves insulin sensitivity within 4–8 weeks), time-restricted eating, and weight loss. A drop from 105 to 88 mg/dL fasting is achievable in 90 days with consistent effort and moves PhenoAge meaningfully.

CRP responds to: anti-inflammatory diet (Mediterranean pattern), sleep optimization (poor sleep is a strong CRP driver), resistance training, reducing alcohol, and treating underlying infections or autoimmune flares. CRP is highly volatile — a temporary illness will spike it; measure it when healthy.

RDW responds to: correcting nutritional deficiencies. The most common drivers of elevated RDW in men over 40 are iron deficiency, B12 deficiency, and folate deficiency. Get a full iron panel and B12 level before supplementing. RDW takes 3–4 months to respond as old red blood cells clear.

Albumin responds to: adequate protein intake (1.6–2.2 g/kg bodyweight daily), resistance training, reducing alcohol (liver function), and treating inflammatory conditions that suppress albumin synthesis.

WBC responds to: smoking cessation (the single biggest WBC driver), weight loss, reducing chronic inflammation through the same interventions that lower CRP.

Lymphocyte % is less directly modifiable through lifestyle than the others. Adequate sleep (7–9 hours), zinc and vitamin D sufficiency, and avoiding chronic stress all support immune cell maintenance.

Limitations to Understand

PhenoAge is a population-level tool calibrated on a US adult population. It estimates biological age based on mortality risk patterns — it does not measure cellular aging directly. Some caveats:

• Acute illness inflates the score. Run it when you're at baseline, not during or just after an infection.
• Renal disease distorts creatinine. If you have known kidney disease, the creatinine term will skew the result.
• It is not a diagnosis. A high PhenoAge warrants a clinical conversation; it does not replace one.
• Epigenetic clocks measure something different. DNA methylation-based biological age clocks (DunedinPace, Horvath's clock) capture epigenetic aging, which PhenoAge does not. They're complementary, not equivalent.

Run PhenoAge as a starting point. It will tell you which systems to investigate, but the clinical picture requires a doctor's interpretation.

FAQ

How often should I calculate my PhenoAge?

Every 6–12 months. The biomarkers that drive PhenoAge change slowly — measuring quarterly doesn't add signal. Run it after making specific interventions (90+ days of a dietary change, a structured training block) to assess response.

My PhenoAge came out higher than my chronological age. What should I do first?

Look at which biomarkers are furthest from their optimal range. RDW and CRP are the highest-coefficient drivers and both respond to actionable interventions. Glucose is the most important for long-term disease risk. Albumin, if low, warrants a clinical visit since it can reflect liver or kidney issues beyond simple nutrition.

Is PhenoAge validated in men specifically?

The original study (Levine 2018) used the full NHANES population, which is roughly equal parts male and female. A 2023 replication (PMID: 36724836) confirmed the formula's predictive validity across sex. The biomarkers carry different absolute values in men vs. women (e.g., creatinine runs higher in men) but the weighted coefficients were derived from the combined population.

How does PhenoAge compare to other biological age tests like TruAge or DunedinPace?

Epigenetic clocks (TruAge, DunedinPace, Horvath's clock) measure DNA methylation patterns — a different layer of biological aging than blood chemistry. They require specialized lab processing and cost $200–$500. PhenoAge uses standard blood work, costs nothing beyond the labs, and correlates meaningfully with mortality in its own right. The two approaches are complementary: epigenetic clocks capture cellular aging rate; PhenoAge captures systemic health status.

Can a young person get an artificially high PhenoAge?

Yes, in certain scenarios. High CRP from a temporary inflammatory state (recent illness, injury, overtraining), or high WBC from an acute infection, will inflate the score temporarily. Always measure at a true baseline. If a young person consistently scores high, it's worth investigating the specific biomarkers driving the elevation — not reassuring themselves based on age alone.

What's a realistic PhenoAge improvement target?

Studies tracking PhenoAge before and after intervention have shown 3–5 year improvements in PhenoAge over 12 months with meaningful lifestyle changes (Mediterranean diet, regular aerobic and resistance training, optimized sleep, alcohol reduction). Larger improvements are possible when baseline scores are significantly elevated, as there's more room to move. Single-digit improvements are clinically meaningful given the 9% per year mortality risk relationship.